跳转至内容
Merck
CN

5.04041

CaCC Blocker IV, Benzbromarone

别名:

CaCC Blocker IV, Benzbromarone, CaCC Blocker IV, Calcium-Activated Chloride Channel Blocker IV, TMEM16 Blocker IV, (3,5-dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone, ANO Blocker IV, Anoctamin Blocker IV, BBR

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C17H12Br2O3
化学文摘社编号:
分子量:
424.08
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

WHQCHUCQKNIQEC-UHFFFAOYSA-N

InChI

1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3

SMILES string

Brc1c(c(cc(c1)C(=O)c2c3c([o]c2CC)cccc3)Br)O

assay

≥97% (HPLC)

form

powder

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, protect from light

color

white

solubility

DMSO: 100 mg/mL

storage temp.

−20°C

Quality Level

General description

A cell-permeable uricosuric agent that, in addition to itsknown efficacy in gout treatment, acts as a reversible CaCC blocker and isreported to be more potent than NFA and NPPB in suppressing500 nM Ionomycin induced I- influx in TMEM16A-expressing HEK293cells (IC50 = 9.97, 140, and 150 µM, respectively) as well as inblocking voltage-gated Cl- current in TMEM16B-expressing HEK293cells, while exhibiting much reduced potency against ENaC (α, β, and γ) orCFTR. Shown to significantly reduce mucin secretion from NHBE (normal humanbronchial epithelial) and suppress human ASM (airway smooth muscle) contractionupon muscarinic receptor stimulation.

Biochem/physiol Actions

Primary Target
TMEM16A-CaCC
Reversible: yes

Packaging

Packaged under inert gas

Preparation Note

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

Other Notes

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Kobayashi, K., et al. 2012. Drug Metab. Pharmacokinet. In press.
Zhang, C.H., et al. 2013. Am. J. Respir. Crit. Care Med.187, 374.
Huang, F., et al. 2012. Proc. Natl. Acad. Sci. USA.109, 16354.
Fujimori, S., et al. 2011. Nucleosides Nucleotides Nucleic Acids30, 1035.
Perez-Ruiz, F., et al. 1998. Ann. Rheum. Dis.57, 545.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Toxic (F)

pictograms

Skull and crossbones

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 3 Oral

存储类别

6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持